Grass Pollen Allergy - Pipeline Review, H2 2017
"The Report Grass Pollen Allergy
- Pipeline Review, H2 2017 provides information on pricing, market
analysis, shares, forecast, and company profiles for key industry
participants. - MarketResearchReports.biz"
About
Grass
Pollen Allergy
Market
Global Markets Direct's latest
Pharmaceutical and Healthcare disease pipeline guide Grass Pollen
Allergy - Pipeline Review, H2 2017, provides an overview of the Grass
Pollen Allergy (Immunology) pipeline landscape.
Grass pollen allergy is a reaction which
occurs soon after exposure to pollen from grasses. Signs and symptoms
include skin reactions, such as hives, redness or swelling, itching
or tingling in or around the mouth and throat, tightening of the
throat, shortness of breath or wheezing and runny nose. Predisposing
factors include age, family history and other allergies.
Report Highlights
Global Markets Direct's Pharmaceutical
and Healthcare latest pipeline guide Grass Pollen Allergy - Pipeline
Review, H2 2017, provides comprehensive information on the
therapeutics under development for Grass Pollen Allergy (Immunology),
complete with analysis by stage of development, drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and
latest news and press releases.
The Grass Pollen Allergy (Immunology)
pipeline guide also reviews of key players involved in therapeutic
development for Grass Pollen Allergy and features dormant and
discontinued projects. The guide covers therapeutics under
Development by Companies /Universities /Institutes, the molecules
developed by Companies in Pre-Registration, Phase III, Phase II and
Preclinical stages are 1, 1, 3 and 2 respectively.
Get
Sample copy of this Report @
https://www.marketresearchreports.biz/sample/sample/1305517
Grass Pollen Allergy (Immunology)
pipeline guide helps in identifying and tracking emerging players in
the market and their portfolios, enhances decision making
capabilities and helps to create effective counter strategies to gain
competitive advantage. The guide is built using data and information
sourced from Global Markets Directs proprietary databases,
company/university websites, clinical trial registries, conferences,
SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources.
Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.
Note: Certain content / sections in the
pipeline guide may be removed or altered based on the availability
and relevance of data.
Scope
- The pipeline guide provides a snapshot
of the global therapeutic landscape of Grass Pollen Allergy
(Immunology).
- The pipeline guide reviews pipeline
therapeutics for Grass Pollen Allergy (Immunology) by companies and
universities/research institutes based on information derived from
company and industry-specific sources.
- The pipeline guide covers pipeline
products based on several stages of development ranging from
pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive
drug profiles for the pipeline products which comprise, product
description, descriptive licensing and collaboration details, R&D
brief, MoA & other developmental activities.
- The pipeline guide reviews key
companies involved in Grass Pollen Allergy (Immunology) therapeutics
and enlists all their major and minor projects.
- The pipeline guide evaluates Grass
Pollen Allergy (Immunology) therapeutics based on mechanism of action
(MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the
dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news
related to pipeline therapeutics for Grass Pollen Allergy
(Immunology)
Reasons to buy
- Procure strategically important
competitor information, analysis, and insights to formulate effective
R&D strategies.
- Recognize emerging players with
potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage.
- Find and recognize significant and
varied types of therapeutics under development for Grass Pollen
Allergy (Immunology).
View
Sample PDF @
https://www.marketresearchreports.biz/reports/1305517/grass-pollen-allergy-pipeline-review-h2-2017-market-research-reports.pdf
- Classify potential new clients or
partners in the target demographic.
- Develop tactical initiatives by
understanding the focus areas of leading companies.
- Plan mergers and acquisitions
meritoriously by identifying key players and its most promising
pipeline therapeutics.
- Formulate corrective measures for
pipeline projects by understanding Grass Pollen Allergy (Immunology)
pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and
out-licensing strategies by identifying prospective partners with the
most attractive projects to enhance and expand business potential and
scope.
- Adjust the therapeutic portfolio by
recognizing discontinued projects and understand from the know-how
what drove them from pipeline.
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Grass Pollen Allergy - Overview
Grass Pollen Allergy - Therapeutics
Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Grass Pollen Allergy - Therapeutics
Assessment
Assessment by Route of Administration
Assessment by Molecule Type
Grass Pollen Allergy - Companies Involved
in Therapeutics Development
ALK-Abello A/S
Allergy Therapeutics Plc
Biomay AG
HAL Allergy BV
Grass Pollen Allergy - Drug Profiles
Allergen for Pollen Grass Allergy Induced
Allergic Rhinitis and Rhinoconjunctivitis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Allergen for Seasonal Grass Pollen
Induced Allergic Rhinitis and Rhino-Conjunctivitis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BM-32 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Pollinex Quattro Grass - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
standardized grass pollen [timothy
(Phleum pratense)] allergen extract - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Vaccine 1 for Grass Pollen Allergy - Drug
Profile
Product Description
Mechanism Of Action
R&D Progress
Vaccine for Grass Pollen Allergy - Drug
Profile
Product Description
Mechanism Of Action
R&D Progress
Grass Pollen Allergy - Dormant Projects
Grass Pollen Allergy - Discontinued
Products
Grass Pollen Allergy - Product
Development Milestones
Featured News & Press Releases
Jan 26, 2017: Biomay AG Reports Positive
Results From A Second Phase IIb Trial With The Innovative 3rd
Generation Grass Pollen Allergy Vaccine BM32
Sep 08, 2016: Grass pollen allergy
vaccine also effective against hepatitis B
Jun 27, 2016: Allergy Therapeutics
announces findings from mEEC dose range finding study G204
Jun 13, 2016: New Data From GAP Landmark
Trial Confirm GRAZAX Prevents Asthma Symptoms in Children
Mar 04, 2016: Inflamax Research Announces
the Successful Completion of Enrollment for the First Multi-center,
Mobile Environmental Exposure Chamber (mEEC) Study
Feb 18, 2016: Allergy Therapeutics
Announces Patient enrolment completed in US Phase IIb study of
GrassMATAMPL
Jan 28, 2016: Biomay initiates new phase
II clinical trial with grass pollen allergy vaccine BM32
Jan 14, 2016: ALK announces top-line
results from the five-year landmark GRAZAX Asthma Prevention trial in
children
Send
An Enquiry Request @
https://www.marketresearchreports.biz/sample/enquiry/1305517
About us
MarketResearchReports.biz is the most
comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Comments
Post a Comment